Neurofeedback Training Therapy: The Future of Treatment Options for Alzheimer’s Disease

This exploratory investigation seeks to evaluate the efficacy of Neurofeedback (NFB) Training Therapy, a type of biofeedback that works with the brain’s natural capacity for plasticity, as a viable treatment for patients with Alzheimer’s Disease (AD). Strengthening connections among remaining neurons despite neurogenesis may benefit patients. However, the vast array of methodologies utilizing different technologies and focusing on varying brain waves makes it challenging to determine the true efficacy of the treatment methods, especially when compounded with the number of disorders each method is claimed to treat. Therefore, this investigation aims to address 1) technology that will best target specific brain areas, and 2) the most suitable NBF protocols for patients with AD. Taken together, this analysis contributes towards assessing the feasibility of NFB as treatment for patients with dementia, leading to the determination that electroencephalography (EEG) NFB with peak alpha or theta brainwave protocols may be the best option.